🇺🇸 ARGENX SEARGX
Get ARGENX SE filings on Telegram the moment they are published.
Follow ARGENX SE on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: Reports positive Phase 2 results for FB102 in celiac disease and the discontinuation of the Phase 3 UNITY study of efgartigimod SC in Sjögren's disease.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest